Multiple Sclerosis News

A new Commonwealth grant for researching multiple sclerosis is expected to advance existing research collaborations and enable new ones.

Express Scripts expects spending on specialty medications in the U.S. to jump 67 percent by the end of 2015, according to a new company study released Tuesday.

In this video, health-care analyst David Williamson discusses Biogen's latest drug up for FDA approval.

The aetiology of multiple sclerosis remains unknown. This hampers molecular diagnosis and the discovery of bio-molecular markers.

A biologics license application has been submitted to the FDA for approval of Plegridy , a pegylated subcutaneous injectable candidate for relapsing forms of multiple sclerosis .

Plegridya is Biogen Idec's newly developed subcutaneously administered multiple sclerosis drug therapy and it as just been announced today that it has been submitted to the FDA for the okay to put on the market.

Main Category: Diabetes Also Included In: Immune System / Vaccines ; Multiple Sclerosis ; Arthritis / Rheumatology Article Date: 21 May 2013 - 1:00 PDT Melbourne researchers have identified an immune protein that has the potential to stop or reverse the development of type 1 diabetes in its early stages, before insulin-producing cells have been ... (more)

A pivotal phase III study of arbaclofen placarbil for the treatment of patients with spasticity due to multiple sclerosis was unsuccessful in demonstrating that the drug provided statistically significant improvement compared with placebo in the trial's co-primary endpoints.

Multiple sclerosis , a neurological disease that affects millions of people all across the world, harms everyone who has this disease is such unbelievable ways and, as of yet, finding a cure has proved incredibly allusive.

XenoPort Inc said it will stop developing its experimental multiple sclerosis treatment after data from a late-stage trial showed the drug did not improve patients' condition significantly compared with a placebo.

In this video, health-care analyst David Williamson discusses why Biogen Idec 's party may just be getting started despite a huge run in the stock already.

'Only cannabis spray relieves my MS - so why won't the NHS give it to me?' Sufferer refused drug to help ease affects of disease Mr Rudd was refused Sativex on the NHS while sufferers living a few miles away are being prescribed the cannabis spray The drug hasn't been assessed by the National Institute for Health and Clinical Excellence - meaning ... (more)

Walk MS brings together people of all walks of life for the common goal of curing the nervous system disease.

A charity supporter is aiming to raise A 10,000 for charity - by travelling 101 miles along the South Downs Way on his mobility scooter.

It is the largest high school science competition in the world and it's happening right here in the Valley.

Working with lab mice models of multiple sclerosis , UC Davis scientists have detected a novel molecular target for the design of drugs that could be safer and more effective than current FDA-approved medications against MS.

The feat, which has been attempted without success for almost two decades, could lead to new treatments for diseases like Parkinson's and multiple sclerosis.

Mike Pawelczak has had MS for over 30 years and leads a group of motorcycle riders, who provide support for cyclists.

Teva's and Active Biotech's laquinimod is a synthetic, once-daily, orally-administered immunomodulator under investigation for the treatment of RRMS.

Paula Sanchez, 23, who was diagnosed with the condition five months ago, gathered together celebrities and cake lovers to raise money for the Multiple Scleroisis Society during an event at the Hyatt Regency Hotel last month.